Search Medical Condition
Please enter condition
Please choose location from dropdown

Post Menopause Clinical Trials

A listing of Post Menopause medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (13) clinical trials

Twelve week study of an estrogen vaginal suppository, six visits, to assess its impact on vaginal dryness and pain in menopausal women.

Phase

Vaginal atrophy, also called (Vaginal Dryness/Irritation/Painful Intercourse), is thinning, drying and inflammation of the vaginal walls due to your body having less estrogen. Vaginal atrophy occurs most often after menopause. For many women, vaginal atrophy makes intercourse painful — and if intercourse hurts, your interest in sex will naturally decrease. ...

Phase N/A

Currently we have the following studies: Birth Control/ Contraceptive Vaginal Atrophy Pain During Intercourse Dysplasia Endometriosis Pap Smear Mammogram Bone Density Osteoporosis Nocturia Uterine Fibroids Uterine Bleeding Post Menopausal Studies HPV STD Hot Flashes

Phase N/A

Diablo Clinical Research is conducting a clinical research study to evaluate an investigational medication in postmenopausal women to see its effect on cholesterol. You may qualify for the study if you are: A woman Post menopausal In good general health Not using hormone therapy Qualified participants may receive at no ...

Phase

Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women

Introduction The daily application of estrogen in the vagina can improve the hydrogen potential (pH), vaginal dryness, burning sensation, dyspareunia, and urinary symptoms. Dyspareunia is highly prevalent after menopause as well as in women after gynecological and breast cancer treatment. However, prescription of topical estrogen therapy (THT) to these women ...

Phase

A clinical trial seeking patients for a research study for the treatment of Gastrojejunostomy, Gastric stapling, Fracture, Perimenopause, Sleeve Gastrectomy, Menopause, Premenopause, Osteoporosis

While highly effective both RYGB and SG may lead to increased bone resorption, decreased bone mass, and increased risk of some fractures. Very few studies have compared the effects of the RYGB and the SG on changes skeletal health and findings have been inconsistent. Furthermore, few studies have investigated the ...

Phase N/A

Sustainability of Vaginal Estrogen Therapy in Postmenopausal Women

Within this trial 50 postmenopausal women receive a vaginal estrogen therapy as treatment for symptomatic vaginal atrophy. The sustainability of vaginal estrogen therapy after the end of therapy has not yet been investigated. All participants will be asked to come for the following 7 visits. Visit 1: Standard Gynecological examination; ...

Phase N/A

Efficacy and Safety of HPC-03 for Postmenopausal Symptom

The results of preclinical efficacy evaluation of HPC-03 (Angelica gigas Nakai complex extract) obtained by mixing materials mentioned above showed that increase of serum estrogen level and increase of bone mineral density (BMD) of femur due to ALP(Alkaline phosphatase ) inhibition, bone related index (BALP,bone-specific alkaline phosphatase ; CTX- 1,C-terminal ...

Phase N/A

Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women

The cognition and attitude of menopausal women toward hormone replacement could have been changed since the report from WHI in July 2002. Previously, many women used hormone replacement to prevent cardiovascular disease and osteoporosis. Recently, the use has been challenged, exaggerated, and also discussed both in media press and academic ...

Phase N/A

Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women

This study will examine whether estrogen administration in postmenopausal women can alter the response to changes in brain chemistry brought about by dietary manipulation. Women who are recently menopausal (50-60 yrs. of age) and over 20 years postmenopausal (>70 yrs. of age) will take estrogen or placebo for three months. ...

Phase